Journal of Traditional Medical Complementary Therapies

.: REVIEW
Kan Basıncını Dengeleyen Doğal Güç: Güncel Yaklaşımlarla Antihipertansif Fonksiyonel Besinler: Geleneksel Derleme
The Natural Power of Regulating Blood Pressure: Antihypertensive Functional Foods with Current Approaches: Traditional Compilations
Nur Sena TUTANa , Kadriye TOPRAKa
aAnkara Medipol Üniversitesi Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, Ankara, Türkiye
J Tradit Complem Med. 2025;8(1):49-58
doi: 10.5336/jtracom.2024-105641
Article Language: TR
Full Text
ÖZET
 Hipertansiyon (HT), Türkiye'de ve dünyada yaygın bir sağlık sorunu olup, kardiyovasküler hastalıkların önde gelen risk faktörlerinden biridir. HT'nin önlenmesi ve tedavisinde, yaşam tarzı değişiklikleri ve beslenme müdahaleleri büyük bir öneme sahiptir. Son yıllarda, fonksiyonel besinlerin antihipertansif özelliklerine odaklanan bir dizi araştırma yapılmıştır. Bu araştırmalar, belirli besinlerin tüketiminin kan basıncını düşürmede etkili olabileceğini göstermektedir. Özellikle sarımsak, çay, hibiskus, nar, ceviz, turunçgiller, keten tohumu, chia tohumu ve kahve gibi besinlerin antihipertansif potansiyeli üzerine yapılan araştırmalar önemli sonuçlar ortaya koymuştur. Sarımsak, içerdiği bileşenler aracılığıyla kan damarlarını genişleterek kan basıncını düşürebilmekte ve antioksidan özellikleri ile de kardiyovasküler sağlığı destekleyebilmektedir. Çay bitkisi oksidatif stresi azaltarak, renin anjiyotensin aldesteron sisteminde iyileşmeler sağlamasıyla, sodyum potasyum pompasının hareketlerini düzenler ve nitrik oksit sentezini artırır bu sayede çayın antihipertansif etki gösterdiği belirtilmektedir. Hibiskus çayı antioksidan özellikleri sayesinde, yüksek kan basıncını düşüren etkileriyle bilinirken, nar ve ceviz gibi besinlerin de renin anjiyotensin aldesteron sistemini inhibe etmesi yönüyle HT üzerinde olumlu etkileri bulunmaktadır. Ayrıca, omega-3 yağ asitleri açısından zengin olan keten tohumu ve chia tohumu gibi besinler de antihipertansif özellikler gösterebilmektedir. Bu fonksiyonel besinlerin günlük beslenme alışkanlıklarına dâhil edilmesi, hipertansiyonun önlenmesi ve kontrol altına alınması ve böylelikle kardiyovasküler sağlığın desteklenmesi açısından önemli bir adım olabilir. Bununla birlikte, fonksiyonel besinlerin HT üzerindeki potansiyel etkilerinin daha iyi anlaşılabilmesi için ileriye dönük daha fazla klinik çalışmaya ihtiyaç vardır. Bu çalışmalar, beslenme ve sağlık arasındaki ilişkiyi daha iyi anlamamıza yardımcı olacaktır.

Anahtar Kelimeler: Antihipertansif besinler; beslenme; fonksiyonel besinler; hipertansiyon
ABSTRACT
 Hypertension (HT) is a prevalent health issue both in Türkiye and worldwide and is one of the leading risk factors for cardiovascular diseases. Lifestyle modifications and nutritional interventions play a significant role in the prevention and treatment of HT. In recent years, a number of studies have focused on the antihypertensive properties of functional foods. These studies indicate that the consumption of certain foods may be effective in lowering blood pressure. Research on the antihypertensive potential of foods such as garlic, tea, hibiscus, pomegranate, walnuts, citrus fruits, flaxseed, chia seeds, and coffee has revealed important findings. Garlic, through its bioactive compounds, can dilate blood vessels and lower blood pressure, while its antioxidant properties also support cardiovascular health. Tea is reported to exhibit antihypertensive effects by reducing oxidative stress, improving the renin-angiotensin-aldosterone system, regulating the sodium-potassium pump, and increasing nitric oxide synthesis. Hibiscus tea is known for its blood pressure-lowering effects due to its antioxidant properties, while foods like pomegranate and walnuts positively impact HT by inhibiting the renin-angiotensin-aldosterone system. Additionally, foods rich in omega-3 fatty acids, such as flaxseed and chia seeds, may also exhibit antihypertensive properties. Incorporating these functional foods into daily dietary habits can be an important step in the prevention and management of HT, thereby supporting cardiovascular health. However, further prospective clinical studies are needed to better understand the potential effects of functional foods on HT. These studies will aid in a more comprehensive understanding of the relationship between nutrition and health.

Keywords: Antihypertensive foods; nutrition; functional foods; hypertension
REFERENCES:
  1. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223-37. [Crossref] [PubMed] [PMC]
  2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957-80. Erratum in: Lancet. 2022;399(10324):520. [PubMed] [PMC]
  3. Onat A, Can G, Yüksel H, Ademoğlu H, Erginel-Ünaltuna N, Kaya A, et al. Tekharf 2017: Tıp Dünyasının Kronik Hastalıklara Yaklaşımına Öncülük. Onat A, editör. 11. baskı. İstanbul: Logos Yayıncılık; 2017.
  4. Aydoğdu A, Atlı T, Bayram F, Can AS, Cesur M, Eren MA, et al. Hipertansiyon Tanı Ve Tedavi Kılavuzu. 6. Baskı. Ankara: Bayt Basın Yayın Hizmetleri; 2022. [Link]
  5. Dağbağlı S, Göksungur MY. Biyoteknolojik Proseslerle Üretilen Biyoaktif Bileşenler. Turkiye Klinikleri Food Sciences - Special Topics. 2023;9(2):47-54. Accessed May 4, 2024. [Link]
  6. Bekhruzjon E, Axmedov K, Jamshidovich S. Образование Наука И Инновационные Идеи В Мире Выпуск Журнала. Hypertension. Classifıcation And Pathogenesis. 2024;38(6). [Link]
  7. Üner S, Balcılar M, Ergüder T. Türkiye Hanehalkı Sağlık Araştırması: Bulaşıcı Olmayan Hastalıkların Risk Faktörleri Prevalansı 2017 (STEPS). Dünya Sağlık Örgütü Türkiye Ofisi, Ankara, 2018.
  8. Crowe KM, Francis C; Academy of Nutrition and Dietetics. Position of the academy of nutrition and dietetics: functional foods. J Acad Nutr Diet. 2013;113(8):1096-103. [Crossref] [PubMed]
  9. Topolska K, Florkiewicz A, Filipiak-Florkiewicz A. Functional food-consumer motivations and expectations. Int J Environ Res Public Health. 2021;18(10):5327. [Crossref] [PubMed] [PMC]
  10. Ansary J, Forbes-Hernández TY, Gil E, Cianciosi D, Zhang J, Elexpuru-Zabaleta M, et al. Potential health benefit of garlic based on human ıntervention studies: a brief overview. Antioxidants (Basel). 2020;9(7):619. [Crossref] [PubMed] [PMC]
  11. Imaizumi VM, Laurindo LF, Manzan B, Guiguer EL, Oshiiwa M, Otoboni AMMB, et al. Garlic: a systematic review of the effects on cardiovascular diseases. Crit Rev Food Sci Nutr. 2023;63(24):6797-819. [Crossref] [PubMed]
  12. Luo Q, Luo L, Zhao J, Wang Y, Luo H. Biological potential and mechanisms of Tea's bioactive compounds: an Updated review. J Adv Res. 2024;65:345-63. [Crossref] [PubMed] [PMC]
  13. Gao J, Akbari A, Wang T. Green tea could improve elderly hypertension by modulating arterial stiffness, the activity of the renin/angiotensin/aldosterone axis, and the sodium-potassium pumps in old male rats. J Food Biochem. 2022;46(12):e14398. [Crossref] [PubMed]
  14. Jeffery TD, Richardson ML. A review of the effectiveness of hibiscus for treatment of metabolic syndrome. J Ethnopharmacol. 2021;270:113762. [Crossref] [PubMed]
  15. Kumar V, Kaur R, Aggarwal Sachdev P, Singh G. Underutilized citrus species: an insight of their nutraceutical potential and importance for the development of functional food. Sci Hortic. 2022;296(1):110909. [Crossref]
  16. Faroughi F, Mohammad-Alizadeh S, Javadzadeh Y, Mirghafourvand M. Effects of garlic pill on blood glucose level in borderline gestational diabetes mellitus: a randomized controlled trial. Iran Red Crescent Med J. 2018;20(5):e60675. [Crossref]
  17. Gao X, Xue Z, Ma Q, Guo Q, Xing L, Santhanam RK, et al. Antioxidant and antihypertensive effects of garlic protein and its hydrolysates and the related mechanism. J Food Biochem. 2020;44(2):e13126. [Crossref] [PubMed]
  18. Li S, Guo W, Lau W, Zhang H, Zhan Z, Wang X, et al. The association of garlic intake and cardiovascular risk factors: A systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2023;63(26):8013-31. [Crossref] [PubMed]
  19. Ried K. Garlic lowers blood pressure in hypertensive ındividuals, regulates serum cholesterol, and stimulates ımmunity: an updated meta-analysis and review. J Nutr. 2016;146(2):389S-396S. [Crossref] [PubMed]
  20. Varade S, Nadella M, Hirake A, Mungase SB, Ali A, Adela R. Effect of garlic on the components of metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. J Ethnopharmacol. 2024;318(Pt B):116960. [Crossref] [PubMed]
  21. Saadh MJ, Kariem M, Shukla M, Ballal S, Kumar A, Chahar M, et al. Effects of aged garlic extract on blood pressure in hypertensive patients: a systematic review and meta-analysis of randomized controlled trials. Prostaglandins Other Lipid Mediat. 2024;175:106914. [Crossref] [PubMed]
  22. Liu Y, Zhao G, Li X, Shen Q, Wu Q, Zhuang J, et al. Comparative analysis of phenolic compound metabolism among tea plants in the section Thea of the genus Camellia. Food Res Int. 2020;135:109276. [Crossref] [PubMed]
  23. Peng X, Zhou R, Wang B, Yu X, Yang X, Liu K, et al. Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Sci Rep. 2014;4:6251. [Crossref] [PubMed] [PMC]
  24. Liu G, Mi XN, Zheng XX, Xu YL, Lu J, Huang XH. Effects of tea intake on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr. 2014;112(7):1043-54. [Crossref] [PubMed]
  25. Khalesi S, Sun J, Buys N, Jamshidi A, Nikbakht-Nasrabadi E, Khosravi-Boroujeni H. Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur J Nutr. 2014;53(6):1299-311. [Crossref] [PubMed]
  26. Mahdavi-Roshan M, Salari A, Ghorbani Z, Ashouri A. The effects of regular consumption of green or black tea beverage on blood pressure in those with elevated blood pressure or hypertension: a systematic review and meta-analysis. Complement Ther Med. 2020;51:102430. [Crossref] [PubMed]
  27. Ye X, Tang X, Li F, Zhu J, Wu M, Wei X, et al. Green and oolong tea extracts with different phytochemical compositions prevent hypertension and modulate the ıntestinal flora in a high-salt diet fed wistar rats. Front Nutr. 2022;9:892801. [Crossref] [PubMed] [PMC]
  28. Da-Costa-Rocha I, Bonnlaender B, Sievers H, Pischel I, Heinrich M. Hibiscus sabdariffa l.-a phytochemical and pharmacological review. Food Chem. 2014;165:424-43. [Crossref]
  29. Edo GI, Samuel PO, Jikah AN, Ifejika MN, Oloni GO, Oghenegueke O, et al. Proximate composition and health benefit of roselle leaf (hibiscus sabdariffa). Insight On Food And Health Benefits. Food Chemistry Advances. 2023;3:100437. [Crossref]
  30. Montalvo-González E, Villagrán Z, González-Torres S, Iñiguez-Muñoz LE, Isiordia-Espinoza MA, Ruvalcaba-Gómez JM, et al. Physiological effects and human health benefits of hibiscus sabdariffa: a review of clinical trials. Pharmaceuticals (Basel). 2022;15(4):464. [Crossref] [PubMed] [PMC]
  31. Bourqui A, Niang EAB, Graz B, Diop EA, Dahaba M, Thiaw I, et al. Hypertension treatment with combretum micranthum or hibiscus sabdariffa, as decoction or tablet: a randomized clinical trial. J Hum Hypertens. 2021;35(9):800-8. [Crossref] [PubMed]
  32. Al-Anbaki M, Cavin AL, Nogueira RC, Taslimi J, Ali H, Najem M, et al. Hibiscus sabdariffa, a treatment for uncontrolled hypertension. Pilot Comparative Intervention. Plants (Basel). 2021;10(5):1018. [Crossref] [PubMed] [PMC]
  33. Abdelmonem M, Ebada MA, Diab S, Ahmed MM, Zaazouee MS, Essa TM, et al. Efficacy of hibiscus sabdariffa on reducing blood pressure in patients with mild-to-moderate hypertension: a systematic review and meta-analysis of published randomized controlled trials. J Cardiovasc Pharmacol. 2022;79(1):e64-e74. [Crossref] [PubMed]
  34. Domènech M, Serra-Mir M, Roth I, Freitas-Simoes T, Valls-Pedret C, Cofán M, et al. Effect of a walnut diet on office and 24-hour ambulatory blood pressure in elderly individuals. Hypertension. 2019;73(5):1049-57. [Crossref] [PubMed] [PMC]
  35. Amadi PU, Agomuo EN, Amadi JA, Bob-Chile Agada AI, Njoku UC, Ogunwa CS, et al. Efficacy of using walnuts as statin adjuvants in hypertension management. Clin Exp Hypertens. 2022;44(5):419-26. [Crossref] [PubMed]
  36. Li J, Jiang B, O Santos H, Santos D, Singh A, Wang L. Effects of walnut intake on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2020;34(11):2921-31. [Crossref] [PubMed]
  37. Tang H, Wang C, Cao S, Wang F. Novel angiotensin I-converting enzyme (ACE) inhibitory peptides from walnut protein isolate: Separation, identification and molecular docking study. J Food Biochem. 2022;46(12):e14411. [Crossref] [PubMed]
  38. Cassidy A, Bertoia M, Chiuve S, Flint A, Forman J, Rimm EB. Habitual intake of anthocyanins and flavanones and risk of cardiovascular disease in men. Am J Clin Nutr. 2016;104(3):587-94. [Crossref] [PubMed] [PMC]
  39. Oude Griep LM, Frost G, Holmes E, Wareham NJ, Elliott P. Systems approach to investigate the role of fruit and vegetable types on vascular function in pre-hypertensive participants: protocol and baseline characteristics of a randomised crossover dietary intervention. nutrients. 2024;16(17):2923. [Crossref] [PubMed] [PMC]
  40. Valls RM, Pedret A, Calderón-Pérez L, Llauradó E, Pla-Pagà L, Companys J, et al. Effects of hesperidin in orange juice on blood and pulse pressures in mildly hypertensive individuals: a randomized controlled trial (Citrus study). Eur J Nutr. 2021;60(3):1277-88. [Crossref] [PubMed] [PMC]
  41. Watanabe Y, Ohata K, Fukanoki A, Fujimoto N, Matsumoto M, Nessa N, et al. Antihypertensive And renoprotective effects of dietary flaxseed and its mechanism of action in deoxycorticosterone acetate-salt hypertensive rats. Pharmacology. 2020;105(1-2):54-62. [Crossref]
  42. Haghighatsiar N, Askari G, Saraf-Bank S, Feizi A, Keshmiri H. Effect of flaxseed powder on cardiovascular risk factor in dyslipidemic and hypertensive patients. Int J Prev Med. 2019;10:218. [Crossref] [PubMed] [PMC]
  43. Toulabi T, Yarahmadi M, Goudarzi F, Ebrahimzadeh F, Momenizadeh A, Yarahmadi S. Effects of flaxseed on blood pressure, body mass index, and total cholesterol in hypertensive patients: a randomized clinical trial. Explore (NY). 2022;18(4):438-45. [Crossref] [PubMed]
  44. Khalid W, Arshad MS, Aziz A, Rahim MA, Qaisrani TB, Afzal F, et al. Chia seeds (Salvia hispanica L.): A therapeutic weapon in metabolic disorders. Food Sci Nutr. 2022;11(1):3-16. [Crossref] [PubMed] [PMC]
  45. Madaan R, Bala R, Zandu SK, Singh I. Formulation and characterization of fast dissolving tablets using salvia hispanica (chia seed) mucilage as superdisintegrant. Acta Pharmaceutica Sciencia. 2020;58(1):69-82. [Crossref]
  46. Chen J, Wu G, Zhu L, Karrar E, Zhang H. A review of the functional activities of chia seed and the mechanisms of action related to molecular targets. Food Funct. 2024;15(3):1158-69. [Crossref]
  47. Rabail R, Khan MR, Mehwish HM, Rajoka MSR, Lorenzo JM, Kieliszek M, et al. An overview of chia seed (Salvia hispanica L.) bioactive peptides' derivation and utilization as an emerging nutraceutical food. Front Biosci (Landmark Ed). 2021;26(9):643-54. [Crossref] [PubMed]
  48. Nikpayam O, Jafari A, Safaei E, Naghshi N, Najafi M, Sohrab G. Effect of chia product supplement on anthropometric measures, blood pressure, glycemic-related parameters, lipid profile and inflammatory indicators: a systematic and meta-analysis. J Funct Foods. 2023;110:105867. [Crossref]
  49. TaghipourSheshdeh F, Behzadi M, Bashiri S, Mohammadi-Sartang M. The effect of chia seed on blood pressure, body composition, and glycemic control: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Nutr Rev. 2025;83(3):448-65. [Crossref] [PubMed]
  50. Karimi M, Pirzad S, Shirsalimi N, Ahmadizad S, Hashemi SM, Karami S, et al. Effects of chia seed (Salvia hispanica L.) supplementation on cardiometabolic health in overweight subjects: a systematic review and meta-analysis of RCTs. Nutr Metab (Lond). 2024;21(1):74. [Crossref] [PubMed] [PMC]
  51. Ullah R, Nadeem M, Khalique A, Imran M, Mehmood S, Javid A, et al. Nutritional and therapeutic perspectives of Chia (Salvia hispanica L.): a review. J Food Sci Technol. 2016;53(4):1750-8. [Crossref] [PubMed] [PMC]
  52. Lima de Castro FBA, Castro FG, da Cunha MR, Pacheco S, Freitas-Silva O, Neves MF, et al. Acute effects of coffee consumption on blood pressure and endothelial function in ındividuals with hypertension on antihypertensive drug treatment: a randomized crossover trial. High Blood Press Cardiovasc Prev. 2024;31(1):65-76. [Crossref] [PubMed]
  53. Rebello Sa, Van Dam Rm. Coffee consumption and cardiovascular health: getting to the heart of the matter topical collection on ischemic heart disease. Curr Cardiol Rep. 2013;15(10):403. [Crossref]
  54. Surma S, Oparil S. Coffee And Arterial Hypertension. Curr Hypertens Rep. 2021;23(7):23-38. [Crossref]
  55. Borghi C. Coffee and blood pressure: exciting news! Blood Press. 2022;31(1):284-7. [Crossref] [PubMed]
  56. Han M, Oh Y, Myung SK. Coffee intake and risk of hypertension: a meta-analysis of cohort studies. J Korean Med Sci. 2022;37(45):e332. [Crossref] [PubMed] [PMC]
  57. Haghighatdoost F, Hajihashemi P, de Sousa Romeiro AM, Mohammadifard N, Sarrafzadegan N, de Oliveira C, et al. Coffee consumption and risk of hypertension in adults: systematic review and meta-analysis. Nutrients. 2023;15(13):3060. [Crossref] [PubMed] [PMC]
  58. Higashi Y. Coffee and endothelial function: a coffee paradox? Nutrients. 2019;11(9):2104. [Crossref] [PubMed] [PMC]
  59. Ghaemi F, Emadzadeh M, Atkin SL, Jamialahmadi T, Zengin G, Sahebkar A. Impact of pomegranate juice on blood pressure: a systematic review and meta-analysis. Phytother Res. 2023;37(10):4429-41. [Crossref] [PubMed]
  60. Yang X, Niu Z, Wang X, Lu X, Sun J, Carpena S, et al. The nutritional and bioactive components, potential health function and comprehensive utilization of pomegranate: a review. Food Reviews International. 2023;39(9):6420-46. [Crossref]
  61. Sreekumar S, Sithul H, Muraleedharan P, Azeez Jm, Sreeharshan S. Pomegranate fruit as a rich source of biologically active compounds. Biomed Res Int. 2014;2014. [Crossref]
  62. Bahari H, Omidian K, Goudarzi K, Rafiei H, Asbaghi O, Hosseini Kolbadi KS, et al. The effects of pomegranate consumption on blood pressure in adults: A systematic review and meta-analysis. Phytother Res. 2024;38(5):2234-48. [Crossref] [PubMed]
  63. Ali MY, Jannat S, Chang MS. Discovery of potent angiotensin-converting enzyme inhibitors in pomegranate as a treatment for hypertension. J Agric Food Chem. 2023;71(30):11476-90. [Crossref] [PubMed]
  64. Gouot JC, Smith JP, Holzapfel BP, Walker AR, Barril C. Grape berry flavonoids: a review of their biochemical responses to high and extreme high temperatures. J Exp Bot. 2019;70(2):397-423. [Crossref] [PubMed]
  65. Raj P, Zieroth S, Netticadan T. An overview of the efficacy of resveratrol in the management of ischemic heart disease. Ann N Y Acad Sci. 2015;1348(1):55-67. [Crossref] [PubMed]
  66. López-Fernández-Sobrino R, Torres-Fuentes C, Bravo FI, Muguerza B. Winery by-products as a valuable source for natural antihypertensive agents. Crit Rev Food Sci Nutr. 2023;63(25):7708-21. [Crossref] [PubMed]
  67. Mas-Capdevila A, Iglesias-Carres L, Arola-Arnal A, Suárez M, Bravo FI, Muguerza B. Changes in arterial blood pressure caused by long-term administration of grape seed proanthocyanidins in rats with established hypertension. Food Funct. 2020;11(10):8735-42. [Crossref] [PubMed]
  68. Ashoori M, Soltani S, Kolahdouz-Mohammadi R, Moghtaderi F, Clayton Z, Abdollahi S. The effect of whole grape products on blood pressure and vascular function: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2023;33(10):1836-48. [Crossref] [PubMed]
  69. Sabra A, Netticadan T, Wijekoon C. Grape bioactive molecules, and the potential health benefits in reducing the risk of heart diseases. Food Chem X. 2021;12:100149. [Crossref] [PubMed] [PMC]
  70. Mashhadi FD, Salari R, Ghorbanzadeh H. The effect of resveratrol dose and duration of treatment on blood pressure in patients with cardiovascular disorders: a systematic review. curr drug discov technol. 2020;17(3):325-31. [Crossref] [PubMed]
  71. Massaro M, Scoditti E, Carluccio MA, Calabriso N, Santarpino G, Verri T, et al. Effects of olive oil on blood pressure: epidemiological, clinical, and mechanistic evidence. Nutrients. 2020;12(6):1548. [Crossref] [PubMed] [PMC]
  72. Serreli G, Deiana M. Biological relevance of extra virgin olive oil polyphenols metabolites. antioxidants (basel). 2018;7(12):170. [Crossref] [PubMed] [PMC]
  73. Alcaide-Hidalgo JM, Margalef M, Bravo FI, Muguerza B, López-Huertas E. Virgin olive oil (unfiltered) extract contains peptides and possesses ACE inhibitory and antihypertensive activity. Clin Nutr. 2020;39(4):1242-9. [Crossref] [PubMed]
  74. Lu Y, Zhao J, Xin Q, Et Al. Protective effects of oleic acid and polyphenols in extra virgin olive oil on cardiovascular diseases. Food Science And Human Wellness. 2024;13(2):529-40. [Crossref]

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 154 - 153
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 197
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 197
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com